Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segment... Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm. Mehr anzeigen
- Treatment with ECUR-506 resulted in a complete clinical response from three months post exposure to the end of study (six months post exposure) - ECUR-506 was generally well tolerated with no...
First in vivo gene insertion clinical trial dosing infants reports complete clinical response in the first participant at the lowest dose level (1.3 x 1013 GC/kg) of ECUR-506 from three months...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.27 | 5.73248407643 | 4.71 | 5.09 | 4.5 | 240013 | 4.80905694 | CS |
| 4 | 0.25 | 5.28541226216 | 4.73 | 7.4399 | 3.61 | 1514386 | 5.54473475 | CS |
| 12 | -3.69 | -42.5605536332 | 8.67 | 9.14 | 3.61 | 525724 | 5.64815567 | CS |
| 26 | -4.97 | -49.9497487437 | 9.95 | 11.09 | 3.61 | 260534 | 6.07116592 | CS |
| 52 | -6.243 | -55.6268377439 | 11.223 | 19.4299 | 3.61 | 217174 | 8.38912119 | CS |
| 156 | -131.52 | -96.3516483516 | 136.5 | 155.997 | 3.61 | 855443 | 35.68350562 | CS |
| 260 | -299.82 | -98.3661417323 | 304.8 | 498 | 3.61 | 776023 | 117.98241391 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
